UNC Science Short: CRISPR/Cas9 to treat Angelman Syndrome

Описание к видео UNC Science Short: CRISPR/Cas9 to treat Angelman Syndrome

Mark Zylka, PhD, director of the UNC Neuroscience Center, is using CRISPR/Cas9 technology to determine if the gene editing method could be used as a cure for Angelman Syndrome, a rare neuro-genetic disorder.

Комментарии

Информация по комментариям в разработке